Category Archives: Loeb

Livermore’s Laws … Positioning

July 7, 2025 By in Artificial Intelligence, David Weis, Livermore, Loeb, NVDA, Positions, Semiconductors, SOXX, SOXX-25-01, Up-Thrust, Wyckoff

Establish Full Position(s) … Early

As the ‘About‘ page says, we’re emulating trading and analysis techniques, used by Livermore, Wyckoff & Loeb.

Livermore’s listed first, as he figured out through many gains and losses, he’s primarily, a strategist:

‘What’s likely to happen, in a big way?’

Wyckoff is next as the tactician, with Loeb as the focus; meaning, concentrate positions, do not ‘diversify’ (not advice, not a recommendation).

Incremental Entries

The potential for reversal in the semiconductor index, started with this post.

From that post, the sidebar shows an initial short, labeled as: SOXX-25-01.

Moving on to this post, Nvidia was used as a proxy for the SOXX; once again, we see SOXX-25-01, in the sidebar.

The short is active, size increased by 50%, last Thursday.

Today, price action posts a new daily low, dips below resistance in 240 – 242, area, increasing probability it’s an up-thrust (reversal).

SOXX-25-01, size increased again by 30%, and we’re done.

The amount of capital planned for the position has been fully allocated.

Set The Stop, & ‘Walk’

From this point, anything can happen.

With that said, the obvious stop location for the current position, is just above today’s high (not advice, not a recommendation).

With a combined entry of 242.26, getting stopped out just above 242.13, would be at break-even.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

A.I. ‘Dominoes’, Start To Fall

February 24, 2025 By in Artificial Intelligence, David Weis, Livermore, Loeb, Positions, Prechter, Semiconductors, South Sea Bubble, SOXS, SOXS-25-08, SOXX, Wyckoff

Data-Center (lease) Cancellations

One of many to come?

The article at this link says the cancellation move was ‘unexpected’.

Clicking on ‘Artificial Intelligence’, (side-bar) and going back to August of ’23, with this post, then reading though subsequent posts, one can say the ‘cancellation’ was fully expected.

That August ’23, post has the link to Prechter’s analysis; we’re in the largest asset bubble in at least 300 years (not advice, not a recommendation).

All of that brings us to chief cook and bottle washer, Nvidia.

Nvidia NVDA, Daily

We’ll cut straight to the chase (as of 11:35 a.m., EST).

A Fibonacci projection is overlaid starting from the all-time-high (1/7/25), to the recent lows (2/3/25), back up to test (2/18/25), then reversal, again.

Note how last Friday’s price action printed and closed near the 23.6, Fibonacci projection.

Positioning

Everyone has their own preference and style.

As stated in the ‘About‘ section, this site works to emulate behaviors of the three masters listed.

That, in addition to the once-in-a-lifetime opportunity to have been mentored by the late David Weis, results in what’s available on this site.

With that said, positioning in the SOXX (the A.I. proxy) is short, via SOXS, as SOXS-25-08, initial entry link here (not advice, not a recommendation).

Note: SOXS-25-08, stop to be moved to the day’s session low; currently 18.58 (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Nvidia … Hanging by a Thread

February 2, 2025 By in Artificial Intelligence, David Weis, Livermore, Loeb, NVDA, Semiconductors, SOXS, SOXS-25-04, SOXX, Wyckoff Tags: , , , ,

Below Support, and Slipping

Does one downside gap, beget another?

The gap-lower open Monday, January 27th, was only retraced by a Fibonacci 23.6%, the next day before continuing lower.

If that percentage holds, it’s a rare occurrence and represents extreme weakness (not advice, not a recommendation).

The chart for NVDA, shows we’ve had the largest down-thrust energy in history (NVDA began trading 1/22/99).

Now, it’s hanging below resistance (blue line).

Nvidia NVDA, Daily

Last Friday closed lower; after-hours, lower, still.

Strategy, Tactics, Focus

As the ‘About‘ section says, techniques on this site are laid out by three masters and coached, mentored, by one of, if not the best in the industry (the late David Weis).

With that said, everyone has their own style.

Currently short the sector via SOXS, as SOXS-25-04 (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Nvidia Melt-Down … The Day After

January 28, 2025 By in Artificial Intelligence, Loeb, NVDA, Semiconductors, South Sea Bubble, SOXS, SOXS-25-03, SOXX Tags: , , , ,

‘Real Opportunities Are Rare’ … Gerald M. Loeb

Now that one pillar of the A.I. mania has vaporized, ‘what’s next?’

To begin the search, let’s start with this headline from yesterday:

“No One Was Buying”: An Ominous Post-Mortem Of What Happened Today From Goldman’s Trading Desk, link here.

That may tell us all we need to know.

But of course, it can’t be that simple. We have to make it complicated with ‘experts’ piling on, pontificating about ‘earnings growth’, ‘multiples’ and the like.

However, did any of that play into identifying the SOXX reversal, almost to the day?

Short answer is, no.

So, why would it be a factor in determining the most likely (next) outcome?

With that, let’s take a look at the chart.

Nvidia NVDA, Daily

It’s an aggressive viewpoint; that is, NVDA’s not going to fill the gap and is in the midst of a sustained down-move (not advice, not a recommendation).

If the A.I. bubble, potentially the largest bubble since the South Sea, imploded yesterday, the chart seems like a reasonable viewpoint (definitely not advice, not a recommendation).

Loeb & Focus

Few people talk about Gerald M. Loeb, late Vice Chairman for E.F. Hutton

He’s the one that said to ‘focus’ one’s efforts on the few and rare, real opportunities.

With that said, NVDA and the SOXX are moving now, while other market appears stagnant.

Therefore, the focus is on this sector (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

SOXX or XBI … Which is ‘Right’?

December 28, 2024 By in $SPSIBI, LABD, LABD-24-21, Loeb, Semiconductors, SOXS, SOXX, SPBIO, XBI

Side by Side

Gearald M. Loeb, late Vice Chairman of E.F. Hutton, said it himself (paraphrasing).

‘If you don’t know what you’re doing (in the markets), you diversify.’

The professionals tend to have highly concentrated positions (not advice, not a recommendation).

With that, let’s look at how two markets have fared during the recent downside reversal.

SOXX & XBI, Daily, Side-by-Side

If you were to position short, which would you choose?

The decline is shown from the exact start-point (Trump ‘bump’) for each market.

Biotech declined -16%, semiconductors, only -10.5%.

More importantly is the rebound (thus far).

Biotech is extremely weak, with only a 23.6% retrace off the lows. Semiconductors have launched all the way back to a 68% retrace.

Why waste time and capital (and increase risk) on a market that’s not moving lower, as quickly as others?

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech, Fibonacci, & The Tape

September 24, 2024 By in $SPSIBI, Biotech, LABD, LABD-24-18, Livermore, Loeb, SOXS, SOXS-24-16, SOXX, SPBIO, Wyckoff, XBI Tags: , , , ,

Reversal of Significance

Wyckoff (tape reading) analysis identified the potential reversal in XBI.

In the past two days of trading, biotech XBI, is decisively lower (not advice, not a recommendation).

However, there’s more to this story.

As we’ll see below, Fibonacci is at work as well.

Biotech XBI, Daily Close

From closing high on 2/27/24, to closing high on 9/19/24, was a Fibonacci 144 days (minus one).

Ladies and Gentlemen, it doesn’t get much better 🙂

The black lines show resistance penetration, up-thrust and reversal.

Livermore, Wyckoff & Loeb

The trading methods of the three market masters above, can be summarized as:

Strategy, Tactics and Focus.

Livermore’s method of ‘what’s going to happen in a (potential) big way’, pointed to biotech.

Wyckoff’s analysis was used to identify (to the day), the potential for a significant reversal.

Loeb, who is less known, was the former Vice Chairman of E.F. Hutton, disparaged ‘diversification’ as the ‘averaging of errors’; meaning, if you don’t know what you’re doing (in the markets), you ‘diversify.’

We can see all three at work in the selection to go short biotech via LABD (not advice, not a recommendation).

Fixing Errors

For those watching, you got to see up close and personal a trading error on shorting the SOXX; specifically, an -11.6%, hit, link here.

As of this post, four trading days later, that loss has been fully recovered and then some.

This is how should be done.

Clear the mind, look for (don’t force) another opportunity, get to back to business.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The Moderna Reversal

June 19, 2024 By in $SPSIBI, Biotech, Dr. John Campbell, Elliott Wave, IBB, Livermore, Loeb, MRNA, PFE, Prechter, SPBIO, Wyckoff, XBI, ZeroHedge 1 Comment

When Price Action Heads South …

Said many times;

‘When price action heads south, bad news comes out.’

That’s a slightly different take on Prechter’s (Elliott Wave) observation.

‘Price action leads the news; not the other way around’.

Going to BigCharts, typing in MRNA, shows they still have no P/E.

So, the ‘bad news’, can’t be they’re not making any money because they’re not doing it, now. 🙂

I wonder, who can it be now?

For a clue to the (potential) answer, we can look at what’s happening to Pfizer, link here and here.

However, let’s not get ourselves wrapped around the axle on events, forecast years ago.

Rather, let’s go straight to the truth, the price action and see what it’s telling us.

Moderna MRNA, Weekly

The entire move from low to highs is shown. Included on the chart, are two Fibonacci indicators.

One is the standard ‘retrace’ indicator; the other, is a ‘projection’ indicator.

The ‘projection’ is based off the ‘a-b-c’ move from the lows of November 2nd, 2023, to the highs on May 24, 2024.

The retrace and projections are hard to see, so the ‘Detail‘, arrow is where we’re headed next on the daily.

Moderna MRNA, Daily

If there ever was a chart to once-and-for-all, refute, dismiss, trash, the whole ‘Fundamentals’ argument, that earnings, interest rates or some other ‘Voodoo economics’, moves prices, this is it:

MRNA, price action hit the 23.6% retrace level (exactly) for two days before moving on to hit the 161.8%, projection (exactly) before reversing.

Note the ‘100%‘ level as well; price action confirmed this area (exactly) three times! Once on the way up and two times on the way down (third time, not shown).

A century ago, Livermore said, ‘It’s all about the numbers’.

Strategy, First

Just as Livermore was primary a strategist, so is this site’s method of analyzing the markets, i.e., Strategy, Tactics, Focus, in that order (not advice, not a recommendation).

The news has been replete with reports like this one and this one.

Another panic ahead?

Sounds like it but at least in the case of Moderna, the chart itself says (effectively):

‘There’s no money in it’.

That means, another wave like we saw several years ago, is not the most likely future event (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Real ‘Opportunities’ Are Rare

March 4, 2024 By in $SPSIBI, Biotech, LABD, Loeb, SPBIO, XBI 1 Comment

When One Is Found …

… It must be used to it’s maximum extent’.

A paraphrased quote from late Gerald M. Loeb, Vice Chairman of E.F. Hutton, Author of: The Battle for Investment Survival.

Here … Now?

Is that where we are with biotech, XBI?

Obviously, the answer won’t be known until it’s all over.

What we do have, is a potential reversal in the making that could be of significance.

No New Highs

At the open today, XBI immediately began to post lower.

It did so without exceeding the prior recovery high set three trading days earlier on February 28th.

Biotech XBI, Daily

The daily chart shows just how close XBI is to a 38.2% retrace. A bigger picture view of that retrace is in the prior update, link here.

It’s obvious we’re still at The Danger Point® where anything can happen.

However, price action tells us, it’s struggling at this area.

A decisive break lower would likely signal a top and significant reversal (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Mind The (Miner) Gap

June 21, 2023 By in DUST, GDX, GDXJ, Gold & Silver, Gold Miners, JDST, Loeb, Neil McCoy-Ward, Positions, Wyckoff, ZeroHedge

‘Straightforward’ … Sort Of

‘Real (market) opportunities are rare. When one is found, it must be used to its fullest extent’; Gerald M. Loeb, the late, and former Vice Chairman, of E.F. Hutton

What a refreshing quote that is, back in the day when we had ‘Chairmen.’.

So, are the Miners the Juniors GDXJ, that opportunity?

From a technical standpoint, there’s the bearish divergence on MACD when looking at the weekly. Then, we have Fibonacci correlation on the weekly as well (shown below).

The daily has the short entry signal given yesterday (not advice, not a recommendation).

Fundamentals Collapse

Next, we have industrial demand in collapse, not to mention the world economies. If industrial demand is collapsing for photovoltaic components (link here), then silver demand must be collapsing.

The ‘Gap’

The analysis was working fine in the pre-market for shorting the GDXJ (not advice, not a recommendation), but then at the open, there was the gap.

Let’s address that but first get started with the weekly chart of GDXJ

Junior Miners, GDXJ, Weekly

The technical details are clear: Bearish divergence on MACD as well as Fibonacci time correlation.

The original Fibonacci 89-weeks was covered in this post.

Yesterday, there was a gap-lower open and price action kept posting lower.

Will this gap be filled? That’s the question.

Junior Miners GDXJ, Daily

As the chart implies, was yesterday a breakaway gap?

Price action’s right at support … or slightly below, which technically put us in Wyckoff ‘spring’ position.

The ‘Probabilities’

Given the bearish overall condition of this sector both on a technical and fundamental basis, a gap-fill is unlikely … but one has to be prepared.

As stated in the last update, the short position via leveraged inverse JDST was increased (not advice, not a recommendation).

To account for possible gap closure on the inverse JDST, a soft stop (trader discretion) is at 6.80 and below, with an absolute hard stop (no excuses exit) at 6.38 (not advice, not a recommendation).

It’s now, 20-minutes before the open.

Let’s see what happens next.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The ‘Santa Claus’ Rally

September 10, 2022 By in $SPSIBI, 2007 - 2008, Biotech, Jerimiah Babe, LABD, LABD-22-05, Livermore, Loeb, Pinball Preparedness, Positions, SPBIO, TDA-LABD-22-02, Wyckoff 2 Comments

That Was it!

It’s going to be a very different place come December.

This won’t be like ’08 -’09, where all the stops are being pulled to ‘rescue’ the market.

No, this time really is different.

We can all see by now; the plan is controlled demolition.

Paraphrasing Jerimiah Babe, and Pinball Preparedness, we haven’t even got started (with the collapse) and the public’s already folding up.

What’s it going to be like when it really hits?

This past week, all the major indices have gone through some type of relief rally. Call it a Santa Claus rally because there probably won’t be one this December.

Trading Consistency

Throughout this upward correction, the case has been made over and again, only biotech SPBIO’s in a technical (and fundamental) condition that would allow it to decline farthest and fastest (not advice, not a recommendation).

Wyckoff analysis along with Livermore’s strategic approach that’s coupled with Loeb’s ‘focus’, has led us to (shorting) this sector exclusively.

Strategy, Tactics, Focus

Biotech SPBIO, Weekly Close

Looking at the far-right side of the chart, SPBIO rallied this past week. It looks like it may head higher … that is, until we put in the trend-lines.

Now, let’s put in the trendlines.

Extended trendlines show the downside potential.

We’re about to see how this works out.

Friday’s upward action in SPBIO slowed with inverse LABD, posting narrow (downside) action as well.

Ready to reverse.

Summary

Trading action in the past week amounted to reducing the position size in LABD-22-05, by about 4.6% (not advice, not a recommendation).

If and when SPBIO continues is downward trajectory, that position (shorting via LABD) will again be increased as the market allows.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279